AI Embryo Selection: What You Should Actually Know in 2026

Over the last three years, "AI-powered embryo selection" has moved from research-stage promise to a marketed add-on at most large IVF programs. Products like Life Whisperer, iDAScore, Alife, and ERICA analyze time-lapse embryo images (and in some cases metadata about your cycle) to generate a numerical score predicting implantation potential. The scores are used to help decide which embryo to transfer first.

This piece walks through what the tools actually do, what the current evidence supports, where legitimate practice ends and marketing begins, and what to ask at consultation before paying for an AI-selection add-on.

What AI Embryo Selection Actually Does

All current AI embryo-selection tools solve the same problem: an embryologist looking at a group of embryos can identify obvious differences (fragmentation, cell number, timing) but has limits on distinguishing between two morphologically similar embryos. AI models trained on thousands of time-lapse image sequences and paired outcome data attempt to detect patterns the human eye misses.

The typical workflow:

1. Your embryos are cultured in a time-lapse incubator (EmbryoScope, Geri, or similar) that photographs each embryo every 5–15 minutes.
2. The AI system analyzes the sequence of images to identify morphokinetic patterns (timing of cell divisions, symmetry, blastocyst expansion).
3. An implantation-probability score is generated for each embryo.
4. The embryologist and REI use the AI score alongside standard morphological grading to prioritize which embryo to transfer.

Important distinction: AI selection is not the same as PGT (preimplantation genetic testing). PGT-A biopsies a few cells from each embryo and tests them directly for chromosomal abnormalities. AI selection is a non-invasive prediction based on visual patterns. The two are separate tools that can be used together or independently.

The Evidence, Honestly

Different claims about AI embryo selection have very different levels of evidence support.

The honest read: AI selection is a legitimate emerging tool with reasonable rationale, some supporting data, and open questions about whether it materially improves outcomes for the typical patient. It is neither a scam nor a proven game-changer.

What You'll Typically Pay for AI Selection

AI selection is nearly always bundled with time-lapse incubation (you can't have one without the other). Typical Colombia pricing:

When AI Selection Actually Adds Value

Multiple similar-looking embryos

If your IVF cycle produces several morphologically comparable blastocysts, the ranking question becomes real. AI can add another data point to help prioritize the transfer order — particularly relevant for programs doing single-embryo transfer where the order of transfers matters.

Frozen embryo cohorts

Patients with multiple frozen blastocysts from prior cycles can benefit from re-analyzing the entire cohort with AI selection before deciding transfer order. This adds analytical rigor to what would otherwise be a decision based only on the embryologist's original grading.

Cycles without PGT-A

Patients who decline PGT-A biopsy but want additional selection guidance may find AI ranking useful. It doesn't tell you which embryos are chromosomally normal — but it may identify which morphologically-good embryos have higher implantation likelihood.

When It's Being Oversold

Sex prediction claims

Some marketing has appeared claiming AI can predict embryo sex from time-lapse images. Beyond being unproven, this crosses into territory that responsible clinics do not enter. Legitimate use of PGT for chromosomal screening (PGT-A) may incidentally reveal sex chromosomes, but sex selection or family balancing is outside the scope of what Colombian responsible IVF practice offers.

What to Ask at Consultation

If AI selection is being offered as part of your treatment package, questions worth asking:

• Which specific AI platform does your clinic use, and what validation studies support it in your patient population?
• Is the AI score used alongside standard morphological grading, or as a replacement?
• What percentage of your embryology decisions are influenced by AI scoring?
• Will I see the AI score for each of my embryos, or only the final ranked list?
• What happens if the AI score disagrees with the embryologist's judgment?
• Is AI selection included in the base package or an add-on cost?

Clinics with a coherent answer to these questions are using AI thoughtfully. Clinics with vague or promotional-only answers may be using it primarily as a marketing tool.

The Colombia Context

Colombia's top IVF programs have adopted time-lapse incubation and AI selection at a pace roughly comparable to major U.S. and European programs. Clinics affiliated with JCI-accredited hospitals typically have access to these technologies. Verifying which specific platform your clinic uses (and its validation history) is worth doing at consultation.

Colombia holds the World Health Organization's #1 healthcare ranking in the Western Hemisphere and #22 globally, per the 2000 World Health Report. Six Colombian hospitals hold JCI accreditation. Fertility physicians registered with ReTHUS (Colombia's national health-professional registry, at rethus.gov.co) can be verified independently. These credentials matter more than any specific technology add-on — a well-credentialed program with standard morphology-based selection will typically outperform a poorly-credentialed program with the latest AI tools.